Dihydroxylation of 4-aryl-1-azido-2-cyclopentenes 6, in which an aryl group is used as a synthetic equivalent of CH(2)OH, was studied to improve the low to moderate stereoselectivity previously reported for cyclopentenes 3 possessing CH(2)X and nitrogen atom-containing groups. 2-Furyl, Ph, and p-MeOC(6)H(4) groups were chosen as the aryl groups. Compounds 6a-c possessing such aryl groups were prepared by CuCN-catalyzed reaction between 2-cyclopentene-1,4-diol monoacetate 9 and the corresponding Grignard reagents followed by substitution of the hydroxyl group with (PhO)(2)P(=O)N(3). The desired diols 7a-c were obtained with higher selectivities of >7:1 when dihydroxylation of 6a-c was carried out at 0 degrees C with OsO(4) (catalyst) and NMO in a mixed solvent of MeCN, THF, t-BuOH, and H(2)O. Among them, the furyl compound recorded the highest selectivity of 14:1. The furyl and azido groups on diol 7a were converted into hydroymethyl and adeninyl groups, respectively, to produce acetonide 2, which upon hydrolysis affords aristeromycin 1.
Nucleic acids
Nucleic acids U 0700Highly Stereoselective Synthesis of Aristeromycin Through Dihydroxylation of 4-Aryl-1-azido-2-cyclopentenes. -It is found that the dihydroxylation of cyclopentene azides containing an aryl substituent in 4-position proceeds with high stereoselectivity. Best selectivity (14:1) is observed with the furyl derivative (IX). The resulting diol can smoothly be transformed into the aristeromycin derivative (XV). -(AINAI, T.; WANG, Y.-G.; TOKORO, Y.; KOBAYASHI*, Y.; J. Org. Chem. 69 (2004) 3, 655-659; Dep. Biomol. Eng., Tokyo Inst. Technol., Midori, Yokohama 226, Japan; Eng.) -Jannicke 25-200
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.